+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Cardiac Assist Devices Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Ventricular Assist Devices , Intra-Aortic Balloon Pumps , Total Artificial Hearts , Extracorporeal Membrane Oxygenation , Percutaneous Ventricular Assist Devices ), By Application (Bridge-to-Transplant , Destination Therapy , Bridge-to-Recovery , Bridge-to-Candidacy ), By Indication (Heart Failure, Cardiogenic Shock, Post-Cardiotomy Recovery), By End-User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Cardiac Assist Devices Market size is forecast to increase from $3.82 Billion in 2026 to $9.8 Billion in 2034 at a CAGR of 12.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006187
Pages: 216 Pages

Cardiac Arrhythmias Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Class I: Sodium-Channel Blockers, Class II: Beta-Blockers, Class III: Potassium-Channel Blockers, Class IV: Calcium-Channel Blockers, Other Anti-Arrhythmic Drugs), By Type of Arrhythmia Indication (Atrial Fibrillation and Flutter, Supraventricular Tachycardia, Ventricular Tachycardia , Bradycardia), By Route of Administration (Oral Dosages, Intravenous ), By Distribution Channel (Hospital Pharmacies, Retail and Community Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Cardiac Arrhythmias Therapeutics Market size is forecast to increase from $5.96 Billion in 2026 to $8.54 Billion in 2034 at a CAGR of 4.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006186
Pages: 223 Pages

Cardiac Arrest Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Medical Devices, Pharmaceutical Drugs), By Device Type (Automated External Defibrillators , Advanced Manual Defibrillators, Extracorporeal Membrane Oxygenation , Mechanical CPR Devices, Intra-Aortic Balloon Pumps ), By Drug Class (Vasopressors and Inotropes, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids and Fibrinolytic Drugs), By Route of Administration (Intravenous , Intraosseous , Oral ), By End-User (Emergency Medical Services , Hospitals and Critical Care , Public Access Facilities and Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Cardiac Arrest Treatment Market size is forecast to increase from $5.86 Billion in 2026 to $8.53 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006185
Pages: 221 Pages

Cardiac Ablation Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Radiofrequency , Cryoablation Devices, Laser Ablation Systems, Ultrasound Ablators, Pulsed Field Ablation , Microwave Ablators), By Approach (Catheter-Based Ablation, Open ), By Application (Atrial Fibrillation & Flutter, Tachycardia , Atrioventricular Nodal Reentrant Tachycardia ), By End-User (Hospitals and Surgical Suites, Ambulatory Surgical Centers , Specialized Cardiac Centers) Companies, and Country Forecast, 2021 to 2034

Global Cardiac Ablation Market size is forecast to increase from $4.14 Billion in 2026 to $8.37 Billion in 2034 at a CAGR of 9.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006184
Pages: 218 Pages

Carcinoembryonic Antigen Market Size, Share and Growth Outlook, 2026: Analysis By Product (Assay Kits, Analyzers & Instruments, Consumables & Reagents), By Test Type (ELISA, Radioimmunoassay, Fluorescence Immunoassay), By Application (Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Breast Cancer, Liver Cancer), By End-User (Hospitals & Surgical Centers, Diagnostic Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Carcinoembryonic Antigen Market size is forecast to increase from $2.55 Billion in 2026 to $3.99 Billion in 2034 at a CAGR of 5.77% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006183
Pages: 222 Pages

Carboxytherapy Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Table-Top Systems, Portable, Standalone, Consumables & Accessories), By Application (Skin Rejuvenation, Cellulite Treatment, Hair Growth Stimulation, Scar Treatment, Stretch Marks, Wound Healing), By End-User (Hospitals, Dermatology & Aesthetic Clinics, Wellness & Beauty Centers, Home-care Settings) Companies, and Country Forecast, 2021 to 2034

Global Carboxytherapy Market size is forecast to increase from $46.78 Billion in 2026 to $110.16 Billion in 2034 at a CAGR of 11.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006182
Pages: 212 Pages

Carboprost Tromethamine Market Size, Share and Growth Outlook, 2026: Analysis By Application (Postpartum Hemorrhage Treatment, Pregnancy Abortion), By Dosage Form (Injectable Solution, Lyophilised Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Carboprost Tromethamine Market size is forecast to increase from $2.44 Billion in 2026 to $3.76 Billion in 2034 at a CAGR of 5.56% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006181
Pages: 229 Pages

Carbon Dioxide (CO2) Incubators Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Water-Jacketed CO2 Incubators, Air-Jacketed CO2 Incubators, Direct Heat CO2 Incubators), By Capacity (Small Capacity , Medium Capacity , Large Capacity ), By Application (Cell Culture & Cancer Research, In-Vitro Fertilization , Stem Cell Research & Regenerative Medicine, Drug Discovery & Pharmaceutical Testing), By End-User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutes, Clinical & Diagnostic Laboratories, Hospitals & IVF Centers) Companies, and Country Forecast, 2021 to 2034

Global Carbon Dioxide (CO2) Incubators Market size is forecast to increase from $971.51 Million in 2026 to $1644.44 Million in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006180
Pages: 228 Pages

Carbapenem Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Meropenem, Imipenem, Ertapenem, Doripenem, Tebipenem, Others), By Route of Administration (Parenteral , Oral), By Indication (Intra-abdominal Infections, Urinary Tract Infections , Pneumonia & Respiratory Tract Infections, Bacterial Meningitis, Sepsis & Skin), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Carbapenem Market size is forecast to increase from $4.14 Billion in 2026 to $5.97 Billion in 2034 at a CAGR of 4.68% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006179
Pages: 218 Pages

CAR T-cell Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Targeted Antigen (CD19, BCMA , CD20, CD22, HER2, GD2, Others), By Therapy Type (Autologous CAR T-cell Therapy, Allogeneic CAR T-cell Therapy), By Disease Indication (Lymphoma, Leukemia , Multiple Myeloma, Solid Tumors), By End-User (Hospitals, Cancer Treatment Centers, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global CAR T-cell Therapy Market size is forecast to increase from $8.67 Billion in 2026 to $38.8 Billion in 2034 at a CAGR of 20.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006178
Pages: 214 Pages